Peter Barton Hutt

CNCE 4,424 shares
MRNA 3,924 shares

The estimated Net Worth of Peter Barton Hutt is at least $114,791.56. Peter Barton Hutt owns over 4,424 units of Concert Pharmaceuticals, Inc. stock worth over $45,611.44.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
23rd October 2020IMMU - Immunomedics, Inc.13,516Sale back to the issuer0$0.00
7th June 2019IMMU - Immunomedics, Inc.9,667Grant/award etc.13,516$0.00
8th August 2019CNCE - Concert Pharmaceuticals, Inc.3,539Open or private sale4,424$10.31$36,487.09$45,611.44
8th August 2019CNCE - Concert Pharmaceuticals, Inc.3,539Exercise of derivative7,963$4.41$15,606.99$35,116.83
17th September 2019MRNA - Moderna, Inc.100,000Open or private sale3,924$17.63$1,763,000.00$69,180.12
17th September 2019MRNA - Moderna, Inc.100,000Exercise of derivative103,924$0.04$4,000.00$4,156.96
20th November 2019MRNA - Moderna, Inc.200,000Open or private sale3,924$20.18$4,036,000.00$79,186.32
20th November 2019MRNA - Moderna, Inc.200,000Exercise of derivative203,924$0.04$8,000.00$8,156.96
18th June 2020IMMU - Immunomedics, Inc.3,718Grant/award etc.17,234$0.00
31st August 2020CNCE - Concert Pharmaceuticals, Inc.3,539Exercise of derivative7,963$3.79$13,412.81$30,179.77